MB CCS - Streamline Health VP eValuator
| STRM Stock | USD 3.02 0.10 3.42% |
Insider
MB CCS is VP eValuator of Streamline Health Solutions
| Address | 2400 Old Milton Pkwy, Alpharetta, GA, United States, 30009 |
| Phone | 888 997 8732 |
| Web | https://www.streamlinehealth.net |
Streamline Health Management Efficiency
The company has return on total asset (ROA) of (0.1054) % which means that it has lost $0.1054 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8009) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to grow to -1.68. In addition to that, Return On Capital Employed is likely to grow to -0.67. At this time, Streamline Health's Other Current Assets are very stable compared to the past year. As of the 22nd of November 2024, Total Current Assets is likely to grow to about 12.7 M, while Non Current Assets Total are likely to drop about 19.4 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Daniel Barton | Forian Inc | 59 | |
| Jason Jones | Health Catalyst | N/A | |
| Gregory MS | National Research Corp | N/A | |
| Andrew Douglas | Forian Inc | N/A | |
| Tyson Murdock | HealthEquity | 53 | |
| Paul Horstmeier | Health Catalyst | 63 | |
| Daniel Burton | Health Catalyst | 49 | |
| Max Wygod | Forian Inc | 36 | |
| Helen Hrdy | National Research Corp | 59 | |
| Jon Boumstein | National Research Corp | N/A | |
| Dave Ross | Health Catalyst | N/A | |
| CPA CPA | National Research Corp | 66 | |
| Michael Vesey | Forian Inc | 62 | |
| David Terrell | Forian Inc | N/A | |
| Jason Alger | Health Catalyst | 40 | |
| Mark Grove | Forian Inc | N/A | |
| Patrick Nelli | Health Catalyst | N/A | |
| Adam Dublin | Forian Inc | 58 | |
| Jona Raasch | National Research Corp | 65 | |
Management Performance
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.11 |
Streamline Health Leadership Team
Elected by the shareholders, the Streamline Health's board of directors comprises two types of representatives: Streamline Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Streamline. The board's role is to monitor Streamline Health's management team and ensure that shareholders' interests are well served. Streamline Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Streamline Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Stilwill, President | ||
| Donald Vick, Director Analytics | ||
| Bryant Reeves, Interim Staff | ||
| Wyche III, Executive Chairman | ||
| Lance Seach, Senior Development | ||
| Jawad Shaikh, Chief Officer | ||
| Benjamin Stilwill, Chief Officer | ||
| Jacob Goldberger, Director FPA | ||
| Wendy Lucio, Chief Officer | ||
| Wendy Lovvorn, Chief Officer | ||
| Amy Sebero, Chief Officer | ||
| Thomas Gibson, CFO, Senior Vice President | ||
| Bryant III, Chief Officer | ||
| MB CCS, VP eValuator |
Streamline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Streamline Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.93) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | 21.26 M | ||||
| Shares Outstanding | 4.22 M | ||||
| Shares Owned By Insiders | 24.07 % | ||||
| Shares Owned By Institutions | 25.97 % | ||||
| Number Of Shares Shorted | 19.66 K | ||||
| Price To Earning | 321.67 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (4.80) | Revenue Per Share 5.249 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.